Editorial commentary: Deconstructing the dogma: Its time to untangle and reassess acute myocardial infarction care

Since first being described clinically over a century ago, the care and outcomes for acute myocardial infarction (AMI) have improved greatly [1]. For the first half of the 20th century, the care for myocardial infarction was driven by biological plausibility of treatment strategies [1], including an emphasis on reducing myocardial oxygen consumption with complete bedrest, increasing myocardial oxygen supply with supplemental oxygen, and sublingual nitroglycerin for coronary vasodilation, as well as symptom relief with intravenous morphine with the intention to limit physical and emotional excursion [1].

Source: Trends in Cardiovascular Medicine - June 20, 2017 Category: Cardiology Authors: Rohan Khera, Dharam J. Kumbhani Source Type: research